Insulin secretion, nutritional status and respiratory function in cystic fibrosis patients with normal glucose tolerance

Clinical Nutrition

Volumn 31, Issue 1, 2012, Pages 118-123

  Alicandro, Gianfranco ^a   Battezzati, Pier Maria ^a   Battezzati, Alberto ^a   Speziali, Chiara ^a   Claut, Laura ^a   Motta, Valentina ^a   Loi, Silvana ^a   Colombo, Carla ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Cystic fibrosis; Growth; Insulin; Nutritional status; Respiratory function

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN;

ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESPONSE; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; ORAL GLUCOSE TOLERANCE TEST; PROTEIN BLOOD LEVEL; RESPIRATORY FUNCTION; SCHOOL CHILD; SEX DIFFERENCE;

ADOLESCENT; AREA UNDER CURVE; BLOOD GLUCOSE; C-PEPTIDE; CHILD; CYSTIC FIBROSIS; FASTING; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; LINEAR MODELS; MALE; NUTRITIONAL STATUS; RESPIRATION; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84856224802     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2011.09.007     Document Type: Article

References (30)

1. Lucidi V., Alghisi F., Raia V., Russo B., Valmarana L., Valmarana R., et al. Growth assessment of paediatric patients with CF comparing different auxologic indicators: a multicentre Italian study. JPediatr Gastroenterol Nutr 2009, 49:335-342.
2. Moran A., Becker D., Casella S.J., Gottlieb P.A., Kirkman M.S., Marshall B.C., et al. Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review. Diabetes Care 2010, 33:2677-2683.
3. Cheung M.S., Bridges N.A., Prasad S.A., Francis J., Carr S.B., Suri R., et al. Growth in children with cystic fibrosis-related diabetes. Pediatr Pulmonol 2009, 44:1223-1225.
4. Rosenecker J., Höfler R., Steinkamp G., Eichler I., Smaczny C., Ballmann M., et al. Diabetes mellitus in patients with cystic fibrosis: the impact of diabetes mellitus on pulmonary function and clinical outcome. Eur J Med Res 2001, 6:345-350.
5. Tofé S., Moreno J.C., Máiz L., Alonso M., Escobar H., Barrio R. Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis. Eur J Endocrinol 2005, 152:241-247.
6. Mohan K., Miller H., Dyce P., Grainger R., Hughes R., Vora J., et al. Mechanisms of glucose intolerance in cystic fibrosis. Diabet Med 2009, 26:582-588.
7. Yung B., Noormohamed F.H., Kemp M., Hooper J., Lant A.F., Hodson M.E. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction. Diabet Med 2002, 19:221-226.
8. Hardin D.S., Leblanc A., Marshall G., Seilheimer D.K. Mechanisms of insulin resistance in cystic fibrosis. Am J Physiol Endocrinol Metab 2001, 281:E1022-E1028.
9. Rolon M.A., Benali K., Munck A., Navarro J., Clement A., Tubiana-Rufi N., et al. Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy. Acta Paediatr 2001, 90:860-867.
10. Lanng S., Thorsteinson B., Nerup J., Koch C. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Paediatr 1992, 15:684-687.
11. Brodsky J., Dougherty S., Makani R., Rubenstein R.C., Kelly A. Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis. Diabetes Care 2011, 34:292-295.
12. Hameed S., Morton J.R., Jaffé A., Field P.I., Belessis Y., Yoong T., et al. Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain. Diabetes Care 2010, 33:221-226.
13. Mohan K., Israel K.L., Miller H., Grainger R., Ledson M.J., Walshaw M.J. Long-term effect of insulin treatment in cystic fibrosis-related diabetes. Respiration 2008, 76:181-186.
14. Nousia-Arvanitakis S., Galli-Tsinopoulou A., Karamouzis M. Insulin improves clinical status of patients with cystic-fibrosis-related diabetes mellitus. Acta Paediatr 2001, 90:515-519.
15. Moran A., Pekow P., Grover P., Zorn M., Slovis B., Pilewski J., et al. Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial. Diabetes Care 2009, 32:1783-1788.
16. Taylor A.M., Thomson A., Bruce-Morgan C., Ahmed M.L., Watts A., Harris D., et al. The relationship between insulin, IGF-I and weight gain in cystic fibrosis. Clin Endocrinol (Oxf) 1999, 51:659-665.
17. Ripa P., Robertson I., Cowley D., Harris M., Masters I.B., Cotterill A.M. The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis. Clin Endocrinol (Oxf) 2002, 56:383-389.
18. Moran A., Hardin D., Rodman D., Allen H.F., Beall R.J., Borowitz D., et al. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract 1999, 45:61-73.
19. Moran A. Evidence based guidelines for cystic fibrosis related diabetes. Diabetes throughout the lifespan symposium. 23rd Annual North American cystic fibrosis conference. Minneapolis, MN 15-17 October 2009.
20. Kuczmarski R.J., Ogden C.L., Guo S.S., Grummer-Strawn L.M., Flegal K.M., Mei Z., et al. 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 11 2002, 246:1-190.
21. Himes J.H., Roche A.F., Thissen D., Moore W.M. Parent-specific adjustments for evaluation of recumbent length and stature of children. Pediatrics 1985, 75:304-313.
22. Lai H.J., Shoff S.M. Classification of malnutrition in cystic fibrosis: implications for evaluating and benchmarking clinical practice performance. Am J Clin Nutr 2008, 88:161-166.
23. Stallings V.A., Stark L.J., Robinson K.A., Feranchak A.P., Quinton H., Clinical Practice Guidelines on Growth and Nutrition Subcommittee; Ad Hoc Working Group Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. JAm Diet Assoc 2008, 108:832-839.
24. Wang X., Dockery D.W., Wypij D., Fay M.E., Ferris B.G. Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol 1993, 15:75-88.
25. Utzschneider K.M., Prigeon R.L., Tong J., Gerchman F., Carr D.B., Zraika S., et al. Within-subject variability of measures of beta cell function derived from a 2 h OGTT: implications for research studies. Diabetologia 2007, 50:2516-2525.
26. Laursen E.M., Juul A., Lanng S., Høiby N., Koch C., Müller J., et al. Diminished concentrations of insulin-like growth factor I in cystic fibrosis. Arch Dis Child 1995, 72:494-497.
27. Taylor A.M., Bush A., Thomson A., Oades P.J., Marchant J.L., Bruce-Morgan C., et al. Relation between insulin-like growth factor-I, body mass index, and clinical status in cystic fibrosis. Arch Dis Child 1997, 76:304-309.
28. Beker L.T., Russek-Cohen E., Fink R.J. Stature as a prognostic factor in cystic fibrosis survival. JAm Diet Assoc 2001, 101:438-442.
29. Enright S., Chatham K., Ionescu A.A., Unnithan V.B., Shale D.J. The influence of body composition on respiratory muscle, lung function and diaphragm thickness in adults with cystic fibrosis. JCyst Fibros 2007, 6:384-390.
30. King S.J., Nyulasi I.B., Strauss B.J., Kotsimbos T., Bailey M., Wilson J.W. Fat-free mass depletion in cystic fibrosis: associated with lung disease severity but poorly detected by body mass index. Nutrition 2010, 26:753-759.